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The aim of the present study was to elucidate the eﬀects of the probiotic feed additive Enterococcus faecium NCIMB 10415
(E. faecium) on porcine jejunal epithelial cells (IPEC-J2) during an in vitro challenge with enterotoxigenic Escherichia coli
(ETEC). Cells were incubated with E. faecium, ETEC, or both, and the eﬀects on barrier function and structure and intra- and
intercellular signaling were determined. Coincubation with E. faecium abolished the ETEC-induced decrease in transepithelial
resistance (Rt) (p ≤ 0 05). No diﬀerences were seen in the expression levels of the intercellular connecting tight junction proteins
examined. However, for the ﬁrst time, a reorganization of the monolayer was observed in ETEC-infected cells but not in
coincubated cells. ETEC induced an increase in cytotoxicity that was prevented by coincubation (p ≤ 0 05), whereas apoptosis
rates were not aﬀected by bacterial treatment. ETEC increased the mRNA expression and release of proinﬂammatory cytokines
TNF-α, IL-1α, and IL-6 which could be prevented by coincubation for TNF-α mRNA expression and IL-6 protein (p ≤ 0 05).
Likewise, cAMP concentrations elevated by ETEC were reduced in coincubated cells (p ≤ 0 05). These ﬁndings indicate a
protective eﬀect of the probiotic E. faecium on inﬂammatory responses during infection with ETEC.
1. Introduction
The gut microbiota has an important impact on immune
responses and barrier function of the intestinal mucosa
and, thereby, inﬂuences overall gut health. Several recent
studies tried to assess the complex cross talk between micro-
biota, intestinal barrier, immune system, and the gut-brain
axis [1, 2]. The high relevance of such cross talk has been
shown for various disease phenotypes such as inﬂammatory
bowel disease, which can be attributed, in part, to perturba-
tions in the composition of the intestinal microbiota [3, 4].
To support the establishment or restoration of a healthy gut
microbiota, probiotics have been proposed as preventive
and therapeutic measures [3]. They have been successfully
applied as a therapy in dysbiosis-associated diseases relevant
in human medicine such as ulcerative colitis [5]. In animal
rearing, probiotics have become valuable tools to prevent
diarrhea in critical production phases and, thereby, exert
positive eﬀects on the performance and health status [6–8].
A very critical period in piglet rearing is weaning
where diarrhea attributable to infections with enterotoxigenic
Escherichia coli (ETEC) represents a major problem [9–11].
Hindawi
Mediators of Inﬂammation
Volume 2017, Article ID 2748192, 13 pages
https://doi.org/10.1155/2017/2748192
The probiotic strain Enterococccus faecium NCIMB 10415
(E. faecium), used in the present study, is a licensed feed
additive for piglets and sows in the EU, and its eﬀects
on diarrhea incidence and performance have been studied
in various feeding trials [7, 12, 13]. It has been found to
reduce diarrhea incidence in piglets in the pre- and post-
weaning period [7, 13], and when applied to sows, it
diminishes piglet loss after birth [13]. It has further been
shown to aﬀect gut immunology [12, 14]. In a previous
study, in vitro coincubation with E. faecium reduced the
decrease in transepithelial resistance (Rt) induced by ETEC
in human colonic and porcine jejunal epithelial cells [15].
The focus of the present study was to examine the eﬀects of
E. faecium on barrier properties and immunological readout
values in a porcine intestinal epithelial cell model in vitro.
The structural barrier of the intestinal epithelium is
formed by the inner lining of intestinal epithelial cells, which
are connected by intercellular junctions. The paracellular
permeability is regulated by tight junction (TJ) structures.
Claudins are the main components of tight junctions.
Some of these proteins, such as claudin-1, claudin-3, and
claudin-5, have sealing functions, whereas others form chan-
nels with selectivity for cations or anions or are permeable to
water [16]. TJ proteins and their localization have been
shown to be regulated by cytokines [17], for example, by
inducing the redistribution of various TJ proteins via inter-
nalization [18] or by regulating the transcription level of TJ
proteins [19].
Based on these prior observations, we examined whether
the protective eﬀects of E. faecium during an ETEC challenge
are attributable to an enhancement of barrier function by
modulating TJ protein expression and localization, the cell
structure, or the vitality of the cells. Furthermore, it was
hypothesized that E. faecium reduces the release of inﬂamma-
tory cytokines during an ETEC challenge. As the heat-labile
toxin of ETEC enhances cAMP production, which can
regulate the expression of proinﬂammatory cytokines [20],
we also assumed that the intracellular concentrations of
cAMP during infection of host cells may be modulated by
the probiotic.
2. Material and Methods
2.1. Cell Culture. Intestinal porcine epithelial cells (IPEC-J2)
were kindly provided by Prof. Dr. Anthony Blikslager
(North Carolina State University, USA). They were culti-
vated as described in Klingspor et al. [15] in DMEM-Ham’s
F12 medium (Biochrom, Berlin, Germany) supplemented
with 5% fetal bovine serum (FBS, Biochrom), 2.5mmol/l
L-glutamine (Biochrom), 5 ng/ml epidermal growth factor
(Biochrom) and ITS (insulin [5μg/ml], transferrin [5μg/ml],
and selenium [5ng/ml]; Sigma-Aldrich Chemie GmbH,
Taufkirchen, Germany), and penicillin-streptomycin (100units
penicillin and 100μg streptomycin/ml, Sigma-Aldrich Chemie
GmbH). Cells were split at a ratio of 1 : 3 every 7 days.
For experiments, cells were either seeded in 24-well cell
culture plates (15mm diameter, TPP, Faust Lab Science,
Klettgau, Germany) or on cell culture inserts (Transwell
Clear, 12mm diameter, 0.4μm pore size [Corning B.V.,
Schiphol-Rijk, The Netherlands], Millicell cell-HA (12mm
diameter, 0.45μmpore size [MerckMillipore Ltd.,Darmstadt,
Germany]) collagenized with rat tail collagen I (Serva
Electrophoresis GmbH, Heidelberg, Germany) at a con-
centration of 105 cells per well or per cell culture insert.
For apoptosis and cytotoxicity assays, cells were cultivated
on 96-well cell culture plates (34mm2, Lumox multiwell,
Sarstedt, Nümbrecht, Germany) at a concentration of 104
cells per well. Before being used in an experiment, the
cells were cultivated for 14–21 days. On the day prior
to experiments, the cells were supplied with serum- and
antibiotic-free media.
2.2. Bacterial Strains. Enterotoxigenic E. coli IMT4818
(ETEC, isolated from a 2-week-old piglet with enteritis,
O149:K91:K88 (F4), positive for the existence of virulence
genes est-1a, est-2 [genes coding for heat stable enterotoxins
I and II], and elt-1a/b [gene coding for heat labile entero-
toxin I] by polymerase chain reaction [PCR]) was grown
in LB medium (Luria/Miller) containing 10 g/l tryptone,
5 g/l yeast extract, and 10 g/l NaCl, at a pH of 7.0 (Roth,
Karlsruhe, Germany).
The probiotic E. faecium NCIMB 10415 strain (from
Cylactin®, DSM, Kaiseraugst, Switzerland) was cultivated in
brain-heart infusion (BHI) broth (OXOID GmbH, Wesel,
Germany). The bacteria were incubated overnight at 37°C
and subcultured for approximately 180min until midlog
phase on a shaker at 37°C, centrifuged, and washed twice
with phosphate-buﬀered saline (PBS, Biochrom). Bacterial
cells were then resuspended in DMEM-Ham’s F12 medium
without penicillin/streptomycin or FBS. The concentration
was adjusted to 108 colony-forming units (CFU)/ml based
on optical density (E. faecium OD=0.9, 600 nm, ETEC
OD=1.3, 600 nm) measured in the Heilos™ Epsilon spec-
trophotometer (Thermo Scientiﬁc, Waltham, USA). The
bacterial concentration was conﬁrmed by serial dilution
followed by determination of viable counts on LB-plates.
2.3. Incubation of Cells with Bacterial Strains. Bacteria (E.
faecium or ETEC) were added to the apical side of cell
culture inserts, 24-well plates, or 96-well plates. The intesti-
nal cells were infected with 106 bacteria per cell culture insert
or well, corresponding to a multiplicity of infection (MOI) of
approximately 10 bacteria per seeded cell. The 96-well cell
culture plates were infected with 105 bacteria per well, which
also equates to an approximate MOI of 10. To test the eﬀect
of E. faecium on ETEC infection, the cells were coincubated
with both ETEC and E. faecium strains. In the coincubation
studies with the probiotic and the pathogenic strains, the cells
were ﬁrst preincubated with E. faecium, and the ETEC strain
was added 2h later. In the following, this setup will be called
“coincubation.” The incubation times given in the legends
were calculated based on the duration of the incubation with
the ETEC strain. After 2 h of incubation with the respec-
tive strains, gentamycin (50μg/ml medium, Biochrom) was
added to kill the bacteria as described in Klingspor et al. [15].
For analysis of cyclic adenosine monophosphate (cAMP),
the incubation time of the respective strains was 4 h and
samples were taken after 4 h of incubation.
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For mRNA expression, protein expression, and confocal
laser scanning microscopy (CLSM), samples were taken at
various time points as indicated in Figure 1.
2.4. Resistance Measurements (Rt). Rt was determined for
cells grown in cell culture inserts with a Millicell-ERS
(Electrical Resistance System; Millipore GmbH, Schwalbach,
Germany). The blank value (cell culture insert and medium
without cells) was subtracted from the measurements,
and the values were corrected for the membrane area.
The Rt values before the beginning of experiments were
3509± 117 Ω·cm2 [mean± SEM].
2.5. Real-Time Quantitative Polymerase Chain Reaction.
Samples for analysis of mRNA expression were taken from
24-well plates. Cell layers were rinsed twice with PBS, and
the cells were harvested in PBS with a cell scraper and
centrifuged (5min, 200 g). RNAlater (Qiagen GmbH, Hilden,
Germany) was added to avoid RNAse degradation, and the
samples were frozen at −20°C. Three wells of a culture plate
were pooled per sample.
The following protocol is described in more detail
by Lodemann et al. [21]. The nucleospin RNA II Kit
(Macherey-Nagel GmbH & Co. KG, Düren, Germany) was
used to isolate total RNA. The RNA concentration was
quantiﬁed by NanoDrop (PEQLAB Biotechnologie GmbH,
Erlangen, Germany). The RNA quality was determined
with a 2100 Bioanalyzer (Agilent Technologies, Böblingen,
Germany), and only samples with an RNA integrity num-
ber above 7 were included in further analyses. cDNA was
synthesized with the iScript™ cDNA Synthesis Kit (Bio-
Rad Laboratories GmbH, Munich, Germany) by reverse-
transcribing 100ng total RNA from the IPEC-J2 cells in
a ﬁnal volume of 200μl in an iCycler iQ™ Real-Time
PCR Detection System (Bio-Rad Laboratories GmbH).
Information about primers for the targets is given in
Table 1. Three reference genes were used for normalization
(GAPDH, TBP, and YWHAZ) as described in Klingspor
et al. [15]. Primers were synthesized by Euroﬁns MWG
Synthesis GmbH (Ebersberg, Germany).
RT-qPCR was conducted in the iCycler iQ Real-Time
PCR Detection System (Bio-Rad Laboratories GmbH) by
using SYBR green I detection. The samples were analysed
in duplicate; the ﬁnal volume of the wells (25μl) contained
iQ SYBR Green Supermix (Bio-Rad Laboratories GmbH),
primers (0.5μl of 20 pmol/μl each), and 5μl cDNA. Controls
included transcription reactions without reverse transcrip-
tase to prove the absence of genomic DNA contamination.
iQ5 software was used for the analysis of the relative amount
of the target genes (Bio-Rad Laboratories GmbH).
2.6. Enzyme-Linked Immunosorbent Assay (ELISA)
2.6.1. IL-6. Supernatants of IPEC-J2 cells were collected
from 24-well plates after 8 h (see Figure 1), centrifuged
(5min, 4000 g, 4°C), and frozen at −80°C until use. Porcine
IL-6 ELISA (Raybiotech, Norcross, USA) was performed
according to the manufacturers’ instructions. Samples were
analysed in duplicate.
2.6.2. IL-1α. Cell-culture supernatants were harvested from
24-well plates after 8 h, centrifuged (5min, 4000 g, 4°C),
and frozen at −80°C until use. IL-1α concentrations were
determined with the Pig Interleukin 1 α (IL-1α) ELISA
Kit (Cusabio, Wuhan, China) according to the manufac-
turers’ instructions. Assays were performed in duplicate.
2.6.3. TNF-α. Supernatants of IPEC-J2 cells were taken from
24-well plates after 8 h, and cell debris was removed by
centrifugation at 4000 g and 4°C. Samples were frozen at
−80°C until use. Quantikine ELISA speciﬁc for porcine
TNF-α (R&D systems, Minneapolis, United States) was
performed according to the manufacturers’ instructions.
Assays were performed in duplicate. To enhance the protein
content, the sample volume was increased to 250μl per
well. Optical density was determined within 30min by
using a microplate reader (EnSpire, Multimode Plate Reader,
Perkin Elmer, Rodgau, Germany). Readings at 540nm were
Sampling
for protein
Washing and addition of gentamycin
Control








in cell culture wells
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E. faecium
E. faecium + ETEC
Figure 1: Experimental set-up.
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subtracted from the readings at 450nm and blank corrected.
A four parameter logistic (4-PL) curve ﬁt was generated for
the calculation of the results.
2.6.4. cAMP. cAMP concentrations were determined by
using the Cyclic AMP XP Assay Kit #4339 (Cell Signaling
Technology, Danvers, United States). On the day prior to
experiments, conﬂuent 24-well plates of IPEC-J2 cells were
washed twice with warm PBS and supplied with serum-
and antibiotic-free media. On the experimental day, cells
were lysed with Roche cOmplete™ Lysis-M (Sigma-Aldrich,
Munich, Germany) after 4 h of bacterial treatment and
centrifuged (5min, 600 g, 4°C), and cAMP ELISA was per-
formed following the manufacturers’ instructions. Assays
were performed in duplicate.
2.7. Apoptosis and Cytotoxicity Assays. Apoptosis and cyto-
toxicity were assessed at 6 h after the addition of the bacterial
strains by using the ApoTox-Glo™ Triplex Assay (Promega,
Madison, USA) according to the manufacturer’s instructions.
This assay measures apoptosis by quantifying caspase-3/7
and cytotoxicity by quantifying dead-cell protease. Excitation
and emission settings for cytotoxicity measurements were set
to excitation 485nm and emission 520 nm. Apoptosis was
determined by luminescence measurements.
2.8. Western Blots. Western blot (WB) analyses were per-
formed by using standard techniques as described in detail
by Amasheh et al. [23]. Primary and secondary antibodies
are given in Table 2. The Lumi-LightPLUS Western Blotting
Kit (Roche, Grenzach Wyhlen, Germany) was used to detect
relevant protein bands via the Fusion FX 7 image acquisition
system (Vilber Lourmat, Eberhardzell, Germany). Densi-
tometric signal analysis was performed by using AIDA
software (Raytest, Berlin, Germany), and β-actin was used
as loading control.
2.9. Confocal Laser Scanning Microscopy. IPEC-J2 cells
grown on membrane supports were washed with PBS
with Ca2+ and Mg2+ and then incubated for 15–20min
in a 2% paraformaldehyde solution at room temperature.
The paraformaldehyde was subsequently deactivated in a
125mmol/l glycine solution. After subsequent rinsing with
PBS containing Ca2+ and Mg2+, preparations were stored in
PBS at 4°C.
For staining, cells were permeabilized in 0.5% Triton-
X100 in PBS (10min) and incubated with primary antibodies
(1 : 200 in PBS, 4°C, overnight). After the cells had been
thoroughly washed, incubation with secondary antibodies
(Jackson ImmunoResearch, Newmarket, UK, Cy2 Fab goat
anti-mouse, Cy5 Fab goat anti-rabbit) was carried out at a
Table 1: Oligonucleotide primers and amplicon length of PCR products.
Gene information Primer sequence Amplicon length Accession number Reference
TNF-α (tumor necrosis factor α,
Sus scrofa)
(S) 5′-GCT GTA CCT CAT CTA CTC CC-3′
291 bp NM_214022.1 [22]
(AS) 5′-TAG ACC TGC CCA GAT TCA GC-3′
IL-6 (interleukin 6, Sus scrofa)
(S) 5′-ATG CTT CCA ATC TGG GTT CA-3′
198 bp M80258.1
(AS) 5′-GTG GTG GCT TTG TCT GGA TT-3′
IL-1α (interleukin 1α, Sus scrofa)
(S) 5′-CAA GGA CAG TGT GGT GAT GG -3′
167 bp NM_214029.1
(AS) 5′-TCA TGT TGC TCT GGA AGC TG-3′
Table 2: Primary and secondary antibodies (WB=Western blot, IF = immunoﬂuorescence).
Antigen Species Company (catalog #) Dilution WB Dilution IF
Primary antibodies
Claudin-1 Rabbit Invitrogen/Thermo Fisher Scientiﬁc (51-9000) 1 : 1000
Claudin-3 Rabbit Invitrogen/Thermo Fisher Scientiﬁc (34-1700) 1 : 1000 1 : 200
Claudin-4 Mouse Invitrogen/Thermo Fisher Scientiﬁc (32-9400) 1 : 5000 1 : 200
Claudin-5 Mouse Invitrogen/Thermo Fisher Scientiﬁc (35-2500) 1 : 1000
Claudin-7 Rabbit Invitrogen/Thermo Fisher Scientiﬁc (34-9100) 1 : 2000
Claudin-8 Rabbit Invitrogen/Thermo Fisher Scientiﬁc (40-2600) 1 : 1000
Occludin Rabbit Invitrogen/Thermo Fisher Scientiﬁc (71-1500) 1 : 200
β-actin Mouse Sigma (A5441) 1 : 10,000
Antigen Species Company (catalog #) Conjugate Dilution WB Dilution IF
Secondary antibodies
Mouse IgG Goat Jackson Immuno Research (115-225-146) Cy2 1 : 600
Rabbit IgG Goat Jackson Immuno Research (111-175-144) Cy5 1 : 600
Mouse IgG Goat Jackson Immuno Research (115-035-003) HRP 1 : 10,000
Rabbit IgG Goat Jackson Immuno Research (111-036-003) HRP 1 : 10,000
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concentration of 1 : 600 together with DAPI (2-(4-amidi-
nophenyl)-1H-indole-6-carboxamidine, ﬁnal concentration
1μg/ml, for 45min at room temperature, Roche Grenzach
Wyhlen, Germany). Preparations were rinsed thoroughly and
embedded in ProTaqs Mount Fluor (Biocyc, Luckenwalde,
Germany). Confocal images were obtained with a con-
focal laser scanning microscope (Zeiss LSM780, Jena,
Germany) by using excitation wavelengths of 405nm,
488nm, and 633nm.
2.10. Calculations and Statistical Analysis. The statistical
analyses and the plotting of graphs were carried out by means
of the SPSS program for Windows, version 23 (Jandel,
Chicago, IL, USA) and Microsoft Excel 2010 (Microsoft
Corporation, Redmond, US).
The statistical signiﬁcance of diﬀerences was assessed by
variance analysis. For Rt values, the expression of cytokines,
measurement of cAMP concentrations, and apoptosis and
cytotoxicity assays, a variance analysis with the ﬁxed factor
“treatment” (“control,” “E. faecium,” “ETEC,” and “E.
faecium+ETEC”) was conducted. If ANOVA indicated a
signiﬁcant diﬀerence, a post hoc Scheﬀé or least signiﬁcant
diﬀerence (LSD) test was conducted per time point to isolate
the means that diﬀered. For the protein expression of TJ pro-
teins, an unpaired Student’s t-test was used. The diﬀerences
between groups were considered statistically signiﬁcant for
p ≤ 0 05. Statistical signiﬁcance is marked in the ﬁgures using
letter coding; means are not diﬀerent if they share the same
letter and are diﬀerent if they do not share at least one com-
mon letter. Results are given as means ± SEM. At least three
independent experiments were conducted, as indicated in the
ﬁgure legends.
3. Results
3.1. Rt. ETEC addition signiﬁcantly reduced the Rt of
IPEC-J2 cells (p ≤ 0 05). This decrease in Rt was reduced
or even prevented by coincubation with E. faecium as
indicated by measurements taken at 4 h, 6 h, and 8h
(p ≤ 0 05) (Figure 2).
3.2. Tight Junction Proteins. The changes in Rt indicated
eﬀects on barrier function. To elucidate whether these
changes were attributable to the altered abundance of TJ
proteins, we examined the expression of selected TJ proteins.
However, in Western blots, no signiﬁcant diﬀerences were
detected in the expression of the TJ proteins claudin-1,
claudin-3, claudin-4, claudin-5, claudin-7, or claudin-8
between bacterial treatments (Figure 3).
3.3. Confocal Laser Scanning Microscopy. Our previous
study had demonstrated the presence of claudin-1, clau-
din-3, claudin-4, claudin-5, claudin-7, and claudin-8 in
IPEC-J2 cells [24]. However, in IPEC-J2 cell layers cul-
tured under the present conditions, only claudin-3 and
claudin-4 showed continuous staining in TJs of all cells.
In addition, occludin appeared to be a reliable TJ marker
in these cell layers. In the present study, we therefore
concentrated on the localization of claudin-3, claudin-4,
and occludin.
By CLSM, no redistribution of claudin-3, claudin-4, and
occludin localization was observed under any experimental
condition. However, for the ﬁrst time, a reorganization of
the epithelial layer was detected in the ETEC-incubated
cells that was largely inhibited by coincubation with E.
faecium (Figures 4 and 5).
3.4. Apoptosis and Cytotoxicity. To investigate the changes
in the epithelial architecture detected by CLSM, the rate
of apoptosis and cytotoxicity was examined. No signiﬁcant
diﬀerences were observed with regard to apoptotic events
between the bacterial treatments of the cells (Figure 6(a)).
However, cytotoxicity was signiﬁcantly increased in the










































Figure 2: Rt in cells incubated with bacterial strains (Ecf, ETEC, and Ecf + ETEC) and in control cells not exposed to bacteria [means ± SEM].
Groups diﬀer signiﬁcantly (P ≤ 0 05) when marked with diﬀerent letters, (e.g., a, b) in the ﬁgure. N = 5 independent experiments.
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cells, E. faecium-incubated cells, or control cells (p ≤ 0 05)
(Figure 6(b)). This represents a novel protective mechanism
of E. faecium during ETEC infection.
3.5. Cytokine Expression. Since the epithelial barrier func-
tion can be inﬂuenced by inﬂammatory cytokines, such
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(a) (b)
Figure 3: Protein expression (Western blot) of claudin-1, claudin-3, claudin-4, claudin-5, claudin-7, and claudin-8 after treatment with
bacterial strains (Ecf, ETEC, and Ecf + ETEC). (a) Protein expression relative to respective controls [means ± SEM]. Samples were taken
after 8 h. No diﬀerences were observed between treatment groups. N = 3 independent experiments per bar. (b) Exemplarily, data of one
Western blot is shown. 1 = control (8 h), 2 = Ecf (8 h), 3 = ETEC (8 h), 4 = Ecf (8 h) + ETEC (6 h), and 5 = Ecf (10 h) + ETEC (8 h). Sample 4
was included as a control to rule out eﬀects of longer total bacterial incubation (preincubation) and was not included in the statistical
analysis shown in (a).
Control Ecf
ETEC Ecf + ETEC
Figure 4: Confocal images of postconﬂuent IPEC-J2 cells at 6 h after treatment with bacterial strains (Ecf, ETEC, and Ecf + ETEC) and
controls (red: claudin-3, green: claudin-4). Under all conditions, claudin-4 was localized in the tight junction and in the lateral membrane.
N = 5 independent experiments.
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cytokines was assessed. IL-6 mRNA expression did not
diﬀer between bacterial treatments (Figure 7(a)). However,
IL-6 protein release into the incubation medium was elevated
in ETEC-incubated IPEC-J2 cells (p ≤ 0 05) (Figure 7(b)).
This eﬀect could be prevented when cells were coincubated
with E. faecium (p ≤ 0 05) (Figure 7(b)).
IL-1α showed only a numerical increase in ETEC-
incubated cells at the mRNA level, but a clear eﬀect was
detected at the protein level (p ≤ 0 05) (Figures 7(c) and
7(d)). The ETEC-induced increase of IL-1α protein was not
reduced by coincubation with E. faecium (Figure 7(d)).
TNF-α was signiﬁcantly upregulated at the mRNA level
in cell lysates and at the protein level in the incubation
medium when cells were incubated with ETEC (p ≤ 0 05)
(Figures 7(e) and 7(f)). Increased release of TNF-α protein
was not inhibited by coincubation with the probiotic
strain; however, upregulation of TNF-α at the mRNA level
was prevented when cells were coincubated with E. faecium
(p ≤ 0 05) (Figures 7(e) and 7(f)).
3.6. cAMP ELISA. Intracellular concentrations of cAMP
were examined, since the heat-labile toxin of ETEC stimu-
lates intracellular cAMP production, which can regulate
the expression of proinﬂammatory cytokines [26]. Our
data showed that the addition of ETEC increased the cAMP
concentration in IPEC-J2 cells at 4 h after commencement
of incubation with ETEC (p ≤ 0 05) (Figure 8). This
increase was attenuated in cells coincubated with E. faecium
(p ≤ 0 05) (Figure 8).
4. Discussion
In the present study, the eﬀects of E. faecium during a
challenge with ETEC were examined in a porcine intestinal
epithelial cell culture model. The eﬀects on epithelial cell
function were analyzed by examining epithelial resistance,
the expression of various TJ proteins, the epithelial cell
structure, cytotoxic cell damage, and apoptosis. Furthermore,
the release of inﬂammatory cytokines and intracellular
cAMP concentrations was assessed.
One important step in revealing the underlying mecha-
nisms of beneﬁcial probiotics on epithelial barrier function
is the investigation of changes in TJ protein expression and
localization. We have shown recently that coincubation with
E. faecium can reduce the eﬀects of ETEC on Rt [15]. Since TJ
proteins are crucial components of the intestinal barrier,
changes at the TJ protein level appeared to be an attractive
explanation for the probiotic eﬀects detected. The intestinal
epithelium represents a single epithelial cell layer which is
interconnected by desmosomes, adherens junctions, and TJ
proteins [27, 28]. TJs are the most apically located and
determine the paracellular permeability. They can either
seal the intercellular space or form selective paracellular
pores [16]. The pathogenic ETEC strain has previously been
shown to impair intestinal barrier integrity in IPEC-J2 cells
through the loss of cell-cell contact, decreased cell viability,
and a broken lining of the TJ adaptor protein zonula
occludens-1 (ZO-1) [29] as well as changes in the expression
and localization of claudin-1 [30, 31]. The present study has
focused on claudin-1, claudin-3, claudin-4, and claudin-5,
which are barrier-forming proteins, claudin-8 conveying a
barrier for cations, and claudin-7, which is involved in
changes in Cl− and Na+ conductance [16, 32–34]. Intrigu-
ingly, in Western blots, no consistent diﬀerences in the
expression levels of the barrier-sealing proteins claudin-1,
claudin-3, claudin-4, claudin-5, and claudin-8 or of
claudin-7 were found after bacterial treatment (Figure 3).
This was unexpected, because ETEC produced profound
eﬀects on electrical tissue resistance (Rt), and coincubation
with E. faecium ameliorated and reversed this eﬀect
(Figure 2). A protective eﬀect on Rt had also been observed
in vitro for other probiotic strains such as Lactobacillus
plantarum, which protected against the barrier disruption
of intestinal epithelial cells challenged with ETEC [31].
Furthermore, treatment with Lactobacillus casei and Butyri-
cicoccus pullicaecorum prevented a TNF-α-induced decrease
in Rt in Caco-2 cells [35, 36]. As a novel ﬁnding, however, our
data indicate that the protective eﬀects of E. faecium on Rt are
not based on changes in the expression of several TJ proteins
but rather depend on changes in epithelial architecture.
Interestingly, in monolayers incubated with ETEC, a
reorganization of the epithelial layer could be observed.
Alterations in ETEC-infected cell layers ranged from single
cells that protruded from the cell layer to dome formation
or a stacked arrangement that seemed to compose a second
epithelial cell layer in some areas. These cells were still
attached to the main cell layer, as judged by their inclusion
into an intact TJ pattern. The observed alterations are sugges-
tive of increased cell shedding in the presence of ETEC.
Control Ecf
ETEC Ecf + ETEC
Figure 5: Confocal images of postconﬂuent IPEC-J2 cells 6 h after
treatment with bacterial strains (Ecf, ETEC, and Ecf + ETEC) and
controls (red: occludin, green: claudin-4). N = 5 independent
experiments.
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Epithelial rearrangement was greatly reduced or completely
prevented in cells that had been preincubated with the
probiotic strain before ETEC application revealing a novel
protective probiotic mechanism during ETEC infection
(Figures 4 and 5). Intestinal epithelial cell shedding and
apoptosis can be induced, for example, by LPS or TNF-α
[37–39]. To elucidate the underlying cellular mechanism,
we examined the rate of apoptosis and cytotoxicity in
the cells and the release of TNF-α and other cytokines.
Our results revealed that diﬀerences in the epithelial struc-
ture are not attributable to apoptotic events but rather seem
to depend on the cytotoxic eﬀects of ETEC (Figure 6). In
agreement with our ﬁndings, Lai et al. [40] have described
increased cytotoxicity without apoptosis in ETEC-infected
J774 macrophages. This commonly indicates that incuba-
tion with ETEC results in the necrosis of individual epi-
thelial cells, an event that leads to localized barrier
failure. Presumably, such focal necrosis and barrier failure
is ameliorated and/or rapidly repaired in E. faecium-
treated cells.
Since epithelial barrier function can be inﬂuenced by
proinﬂammatory cytokines [25], changes in the cytokine
response could further explain the ﬁnding that E. faecium
prevents the ETEC-induced decrease in Rt.
Cytokines are able to mediate communication between
cells of the immune system, hematopoietic cells, and other
cell types [41]. They are expressed not only by immune cells,
but also by intestinal epithelial cells [42, 43]. In the present
study, we have focused on a well-established set of inﬂam-
matory cytokines including IL-6, IL-1α, and TNF-α [44].
Assuming the probiotic E. faecium to have protective eﬀects,
we hypothesized that the probiotic strain would decrease
the inﬂammatory cytokine expression caused by an ETEC
infection. IL-6 is one of the most crucial inﬂammatory
cytokines. However, IL-6 also has a protective function
within the intestine. It prohibits epithelial apoptosis during
ongoing inﬂammation and is necessary for epithelial pro-
liferation [45]. In intestinal epithelial cells, IL-6 is required
for the regeneration and for the maintenance of the bar-



































































Con Ecf ETEC Ecf + ETEC
(b)
Figure 6: Apoptosis (a) and cytotoxicity (b) of IPEC-J2 cells after treatment with bacterial strains (Ecf, ETEC, and Ecf + ETEC) or without
bacteria (Con = control) as assessed by caspase-3/7 activity in luminescence assay for apoptosis and by a dead cell protease ﬂuorescence
assay for cytotoxicity [means ± SEM]. Measurements were taken after 6 h. Groups diﬀer signiﬁcantly (P ≤ 0 05) when marked with
diﬀerent letters, (e.g., a, b) in the ﬁgure. N = 4 (apoptosis assay) and N = 5 (cytotoxicity assay) independent experiments.
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lead to increased epithelial TJ permeability in Caco-2
cells [48–50]. On the other hand, the in vitro study of
Suzuki et al. has revealed that claudin-1, claudin-3, and
claudin-4 are not aﬀected by IL-6 in Caco-2 cells. Our results
indicate that the release of IL-6 is signiﬁcantly reduced in
coincubated cells compared with cells infected with ETEC
alone (Figure 7(b)). Since IL-6 mostly functions as a proin-
ﬂammatory cytokine, E. faeciummight reduce inﬂammation
during an ETEC infection. However, IL-6 might also be
released in ETEC-incubated cells as a self-protective mecha-
nism of the cells directed, for example, at the inhibition of
apoptosis [45]. In either case, E. faecium seems to have a
protective eﬀect on the cells, as the stimulus for the release
of IL-6 is inhibited by coincubation with this probiotic strain.
IL-1α exerts proinﬂammatory signals [51, 52] and is
often released upon cell death [26]. It is physiologically
attached to the cell nuclei, but translocates to the cytosol
in the case of cell necrosis [53]. It provokes potent
proinﬂammatory eﬀects and is involved in neutrophil
recruitment [52]. Moreover, IL-1 augments IL-8 expression
and production in various cells [54]. In the present study,
we could not detect any signiﬁcant eﬀects of the various
bacterial treatments on the IL-1α mRNA level (Figure 7(c)).
However, the release of IL-1α is signiﬁcantly increased in
ETEC-incubated and coincubated cells (Figure 7(d)). The
latter indicates that the protective eﬀects of E. faecium most
likely do not depend on the modulation of IL-1α release.
TNF-α is an inﬂammatory cytokine that can promote
apoptosis or the proliferation of cells [55]. Two forms of
biologically active TNF-α are known: the membrane-bound
and the soluble TNF-α [56]. In inﬂammatory bowel disease
(IBD) patients, TNF-α is a crucial player that causes the loss
of intestinal epithelial barrier integrity and stimulates the
release of other proinﬂammatory cytokines [57]. TNF-α
increases epithelial cell shedding, which can reduce intestinal
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Figure 7: mRNA expression of IL-6 (a), IL-1α (c), and TNF-α (e) and cytokine release of IL-6 (b), IL-1α (d), and TNF-α (f) from IPEC-J2 cells
after treatment with bacterial strains (Ecf, ETEC, and Ecf + ETEC) or without bacteria (Con = control) [means ± SEM]. Samples were taken
after 4 h (mRNA) or 8 h (protein release). Groups diﬀer signiﬁcantly (P ≤ 0 05) when marked with diﬀerent letters, (e.g., a, b) in the ﬁgure.
N=number of independent experiments as indicated in the ﬁgure caption.
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cells and Caco-2 cells [59, 60]. At the TJ level, TNF-α
redistributes various TJ proteins [39, 61, 62]. In the present
study, the mRNA expression of TNF-α is signiﬁcantly
increased 4 h after ETEC infection, whereas coincubation
with E. faecium abolished this eﬀect (Figure 7(e)). Wu
et al. [31] obtained similar ﬁndings for TNF-α expression
in IPEC-J2 cells incubated with the probiotic strain Lactoba-
cillus plantarum and challenged with ETEC. Intriguingly, in
our study, we could not detect a similar eﬀect at the protein
level (Figure 7(f)). The latter observation suggests that the
release of TNF-α was rather small and could only be detected
in the ELISA by increasing the sample volume to improve
sensitivity. At such a low release level, the applied test may
easily miss a possible decrease of TNF-α production when
cells are coincubated with the probiotic strain (Figure 7(f)).
Cyclic AMP is a second messenger whose intracellular
concentrations are adjusted by adenylate cyclase (AC) and
cyclic nucleotide phosphodiesterase (PDE). AC heightens
the level of cAMP, whereas PDE reduces its concentration
in the cell. Cyclic AMP mainly activates protein kinase A
(PKA), the GTP exchange protein directly activated by cAMP
(EPAC) and cyclic nucleotide-gated ion channels [63]. Tran-
scription factors modulating cytokine expression can be also
regulated by cAMP [63]. Many triggers inﬂuence cAMP
levels via AC and PDE, such as nutrients, hormones, neuro-
transmitters, pheromones, calcium, bicarbonate, CO2, and
cAMP itself [64]. The heat-labile toxin (LT) released by
ETEC stimulates AC, and the resulting increases in cAMP
concentrations and PKA activity lead to opening of chloride
channels such as cystic ﬁbrosis transmembrane conductance
regulator (CFTR) to induce intestinal ﬂuid secretion and
diarrhea [65, 66]. In the present study, the intracellular levels
of cAMP are signiﬁcantly increased in cells incubated
with ETEC, thus indicating the release of LT by ETEC
(Figure 8). When the cells are coincubated with E. faecium,
however, the increase in cAMP concentrations is alleviated
(Figure 8). The latter ﬁrstly indicates that E. faecium protects
the cells at an early state of ETEC infection, since the release
of LT, which upregulates the cAMP response, is one of the
early events of ETEC pathogenesis upon its adherence to
the intestinal mucosa.
5. Conclusions
The present study reveals that ETEC infection of IPEC-J2
cells leads to barrier failure via cytotoxic insults that trigger
the necrosis of individual cells and subsequently alter epithe-
lial architecture. Preexposure to the probiotic E. faecium has
beneﬁcial eﬀects on subsequent ETEC infection via the
downregulation of certain inﬂammatory cytokines, reduced
cytotoxicity, and decreased concentrations of the second
messenger cAMP. Our study has further conﬁrmed results
of a former investigation in which protective eﬀects of E.
faecium were observed on the Rt decrease induced by ETEC.
We now demonstrate for the ﬁrst time, however, that these
eﬀects cannot be attributed to changes in the expression
levels of several tested TJ proteins but might be based on
the ability of E. faecium to prevent cell death and to preserve
the physiological epithelial cell structure in coincubated cells.
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